May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Calpain Inhibitor Reverses VEGF-Induced Endothelial Cell Motility and Tube Formation in vitro
Author Affiliations & Notes
  • H. Ma
    Integrative Biosciences, Oregon Health & Science University, Portland, Oregon
  • M. Azuma
    Senju Laboratory & Ocular Sciences, Beaverton, Oregon
    Senju Pharmaceutical Co, Kobe, Japan
  • T. R. Shearer
    Integrative Biosciences, Oregon Health & Science University, Portland, Oregon
  • Footnotes
    Commercial Relationships  H. Ma, None; M. Azuma, Senju Pharmaceutical, E; T.R. Shearer, Senju Pharmaceutical, C.
  • Footnotes
    Support  NEI grant EY05786
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 858. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H. Ma, M. Azuma, T. R. Shearer; Calpain Inhibitor Reverses VEGF-Induced Endothelial Cell Motility and Tube Formation in vitro. Invest. Ophthalmol. Vis. Sci. 2008;49(13):858. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Vascular endothelial growth factor (VEGF) is an important regulator of angiogenesis and microvascular permeability. VEGF-induced cytoskeletal reorganization plays a crucial role in angiogenesis (1). Cytoskeletal organization in endothelial cells is regulated by calpain cysteine proteases (2). Calpains are a family of 14 calcium-regulated intracellular proteases, which modulate cellular function by limited, specific proteolysis. Calpain-1 (µ-calpain) and calpain-2 (m-calpain) are the two major typical calpain isoforms and are responsible for most calpain activity in endothelial cells. The purpose of the present study was to determine if an orally available form of calpain inhibitor, SNJ-1945, reversed angiogenesis induced by VEGF in vitro.

Methods: : Human retinal microvascular endothelial cells (HREC) were incubated with VEGF (60-100 ng/ml) for 24 h. Total calpain activities were determined by casein zymography. Proteolysis of endogenous calpain substrate α-spectrin in situ and autolysis of calpain were analyzed by immunoblotting. Angiogenesis in vitro was evaluated by measuring cell migration and tube formation into Matrigel.

Results: : Incubation of HREC with VEGF resulted in increased activity of mainly m-calpain. VEGF also increased calpain activation as measured by increased proteolysis of α-spectrin and increased amounts of the autolytic 43kDa fragment of calpain. When the retinal soluble proteins from microvascular endothelial cells were incubated with calcium, calpain activation and autolysis occurred. Treatment of endothelial cells with calpain inhibitor SNJ-1945 reversed VEGF-mediated tube formation and cell motility.

Conclusions: : Our results suggested that orally available calpain inhibitor SNJ-1945 might be a possible candidate drug for management of pathological angiogenesis occurring in wet AMD and proliferative retinopathy.1. Leung DW, et al. (1989) Science 26, 1306-13092. Kulkarni S, et al. (2002) J. Biol. Chem. 277, 24435-24441

Keywords: vascular endothelial growth factor • drug toxicity/drug effects • proteolysis 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×